Cancer immunotherapy .net
Information on human tumours 1
tumour type
Pulmonary metastases of renal cancer
Data in short:

Five-year survival:
0% without local IL-2
21% with local IL-2

Local IL-2 is new standard treatment
Huland and Heinzer, 2003
Huland and Heinzer, 2004
Huland et al., 2004
tumour type
Interleukin-2 (IL-2)
Mechanism of IL-2 therapy of cancer

Cancers sensitve to IL-2
Surgery and IL-2
Radiotherapy and IL-2
Chemotherapy and IL-2

I want to co-operate (doctors)
Frequently Asked Questions (FAQs)
Information for doctors
Information for patients
I want to support this research or  more information on the EPTI fund supporting this research
Stichting ter bevordering van het onderzoek in de Experimentele Pathologie en in het bijzonder in de TumourImmunologie. Stichting EPTI, IJselstein, The Netherlands